Acasti Pharma | ACST - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acasti Pharma USD 18.67M 1.81M 2025-12
Addus HomeCare USD 99.57M 3.5M 2026-06
Amarin USD 143.56M 12.5M 2026-06
Cassava Sciences USD 86.57M 8.93M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Option Care Health USD 193.77M 16.45M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Tilray USD 264.83M 43.16M 2025-06